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the level of known risk factors of CVD. Nevertheless,
mobile screening unit is a good method for increasing
the awareness of the public.
http://dx.doi:10.1016/j.jsha.2012.06.252
Two years follow up of patients who underwent
trans-catheter aortic valve implantation at Prince
Sultan Cardiac Center (TAVI)
Saeed Al Ahmari, Mohammed Al Otabi, Saad Al
Kasab, Adel Tash, Moheeb Al Abdullah, Husien Al
Amri
Objectives: We report our two years clinical, and
echo follow up of patients who underwent trans-apical
and trans-femoral TAVI.
Methods: All patients who underwent TAVI therapy
have been followed at six, 12, and 24 months, where clin-
ical, and echo evaluation have been obtained.
Results: Sixty-six pat were operated, with mean age
of 78.7 ± 9.3 y, 53% females, and 47% males. The mean
logistic Euro score was 21 ± 8. 55% of pat completed 2
years follow-up. Fourty-two pat received Edward Sapien
valve (25 trsna-apical, and 17 trans-femoral ), and 24 pat
received core valve. Thirty days mortality in Sapien valve
group was 11%, and 0% in Core valve group. CVA devel-
oped in 8% of the core valve group, and 7% of the Sapien
valve group. Complete heart block developed in 37.5 of
Core group, and 4.8% of the sapien group. Peripheral
arterial complications occurred in 12.5% of Core patients,
and 5.8% of Sapien patients. On follow up, patient’s
symptoms improved. The PG decreased from
88 ± 22 mmHg to 19 ± 7 mmHg, P < 0.0001, and the mitral
regurgitation (MR) severity grade decreased from
1.6 ± 1.1 to 0.9 ± 0.6, P < 0.001. Paravalvular leak was mild
in 15.2%, and moderate in 6.1% of patients.
Conclusion: TAVI is promising technique in treating
patients with severe AS with acceptable mortality rate.
There was significant improvement in patient’s symp-
toms, reduction in aortic gradient and reduction in MR
severity.
http://dx.doi:10.1016/j.jsha.2012.06.253
Routine invasive versus ischemia-guided strategy
in patients with acute inferior ST-elevation myo-
cardial infarction who received fibrinolytic ther-
apy: A prospective randomized controlled pilot
trial
Samah Abdul-Rahman, Wail Nammas, Adel
Gamal, Amr Adel, Tarek Zaki
Aims: We sought to compare a routine invasive strat-
egy of early coronary angiography and intended revascu-
larization, with an ischemia-guided strategy in patients
with acute inferior ST elevation myocardial infarction
(STEMI) who received fibrinolytic therapy.
Methods: We enrolled 60 consecutive patients with
acute inferior STEMI who received fibrinolytic therapy
within 6 h. Patients were randomly assigned to either a
routine invasive strategy in which coronary angiography
was performed within 48 h with intended revasculariza-
tion if eligible (Group A), or an ischemia-guided strategy
in which catheterization was based on the presence of
myocardial ischemia and viability as demonstrated by
stress myocardial perfusion imaging (Group B). Patients
were prospectively followed up for 6 months. The pri-
mary endpoint was a composite of cardiac death, recur-
rent myocardial infarction, recurrent ischemia or stroke
at 6-month follow-up. Total costs per patient were calcu-
lated over 6 months.
Results: The mean age of the whole series was
52 ± 9.8 years (15% females). The primary endpoint
occurred more frequently in group A as compared to
group B, however, the difference did not meet statistical
significance (36.7% versus 23.3%, respectively, p > 0.05).
The mean cost per patient at 6-month follow-up was sig-
nificantly higher in Group A as compared to that in
Group B ($4953.5 ± 3108.5 versus $2764.6 ± 2636.7, respec-
tively, p < 0.01).
Conclusions: In patients presenting with inferior
STEMI who received fibrinolytic therapy, a routine inva-
sive strategy with early coronary angiography and
intended revascularization, achieved a clinical outcome
similar to an ischemia-guided strategy; yet, at a signifi-
cantly higher cost.
http://dx.doi:10.1016/j.jsha.2012.06.254
Impact of chylothorax on the post operative out-
come after pediatric cardiovascular surgery
Sameh R. Ismail, Mohamed S. Kabbani, Hani K.
Najm, Ghassan A. Shaath, Abdulraouf M.Z. Jijeh
Background: Chylothorax is the accumulation of
chyle in the pleural cavity, usually develops after disrup-
tion of the thoracic duct along its intra-thoracic route. In
the majority of cases this rupture is secondary to trauma
(including cardio thoracic surgeries). Chylothorax is a
potentially serious complication after cardiovascular sur-
geries that require early diagnosis and adequate
management.
Methods: A retrospective study of all cases compli-
cated with chylothorax after pediatric cardiac surgery in
King Abdulaziz Cardiac Center between January 2007
and December 2009 was conducted. The study aim to
determine the risk factors, and the impact on the post
operative course.
Results: We have 1135 cases operated during the
study period, 57 cases (5%) were complicated with chylo-
thorax in the post operative period. The most common
surgeries complicated with chylothorax were the single
ventricle repair surgeries (Glenn-Fontan) 15 cases
(27%), followed by the arch repair cases 10 cases (18%),
the ventricular septal defect cases 10 cases (18%), the
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